CStone Pharmaceuticals (HKG:2616)
Hong Kong
· Delayed Price · Currency is HKD 9.49
+0.07 (0.74%)
Apr 29, 2026, 4:08 PM HKT
CStone Pharmaceuticals Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Net Income | - | -91.21 | -367.23 | -902.68 | -1,920 | Upgrade
|
| Depreciation & Amortization | - | 49.74 | 56.93 | 42.03 | 20.06 | Upgrade
|
| Other Amortization | - | 0.07 | 1.27 | 2.51 | 2.6 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | -0.38 | -178.89 | - | 0.9 | Upgrade
|
| Asset Writedown & Restructuring Costs | - | 10.73 | 26.4 | 23.41 | - | Upgrade
|
| Loss (Gain) From Sale of Investments | - | -6.01 | -0.06 | 62.03 | 64.21 | Upgrade
|
| Stock-Based Compensation | - | -2.81 | 36.99 | 142.06 | 222.67 | Upgrade
|
| Other Operating Activities | - | -2.31 | -26.8 | -54.48 | 85.93 | Upgrade
|
| Change in Accounts Receivable | - | 48.51 | -95.31 | 40.47 | -117.6 | Upgrade
|
| Change in Inventory | - | -174.9 | -95.46 | 30.42 | -86.18 | Upgrade
|
| Change in Accounts Payable | - | -170.1 | -121.6 | -3.1 | 153.08 | Upgrade
|
| Change in Unearned Revenue | - | 35 | 70 | - | -6.76 | Upgrade
|
| Change in Other Net Operating Assets | - | -39.51 | 104.92 | 6.59 | 97.17 | Upgrade
|
| Operating Cash Flow | - | -343.18 | -588.84 | -610.74 | -1,484 | Upgrade
|
| Capital Expenditures | - | - | -0.02 | - | -91.03 | Upgrade
|
| Sale of Property, Plant & Equipment | - | 0.41 | 0.11 | - | - | Upgrade
|
| Sale (Purchase) of Intangibles | - | - | 151.57 | -101.82 | -58.11 | Upgrade
|
| Investment in Securities | - | -254.13 | 447.69 | 463.81 | -687.48 | Upgrade
|
| Other Investing Activities | - | 6.05 | 20.25 | 1.41 | 10.06 | Upgrade
|
| Investing Cash Flow | - | -247.68 | 619.61 | 363.39 | -826.55 | Upgrade
|
| Short-Term Debt Issued | - | 39.97 | - | - | - | Upgrade
|
| Long-Term Debt Issued | - | 278 | 350 | 113.04 | 96.22 | Upgrade
|
| Total Debt Issued | - | 317.97 | 350 | 113.04 | 96.22 | Upgrade
|
| Long-Term Debt Repaid | - | -312.02 | -289.98 | -75.3 | -18.5 | Upgrade
|
| Net Debt Issued (Repaid) | - | 5.95 | 60.02 | 37.75 | 77.72 | Upgrade
|
| Issuance of Common Stock | - | 0.07 | 341.82 | 2.53 | 16.83 | Upgrade
|
| Other Financing Activities | - | -18.92 | -13.49 | -11.81 | -2.24 | Upgrade
|
| Financing Cash Flow | - | -12.9 | 388.36 | 28.47 | 92.3 | Upgrade
|
| Foreign Exchange Rate Adjustments | - | -4.98 | 18.87 | 34.84 | -63.55 | Upgrade
|
| Net Cash Flow | - | -608.73 | 437.99 | -184.04 | -2,282 | Upgrade
|
| Free Cash Flow | - | -343.18 | -588.86 | -610.74 | -1,575 | Upgrade
|
| Free Cash Flow Margin | - | -84.28% | -126.95% | -126.88% | -646.26% | Upgrade
|
| Free Cash Flow Per Share | - | -0.27 | -0.47 | -0.52 | -1.35 | Upgrade
|
| Cash Interest Paid | - | 11.9 | 10.18 | 11.81 | 2.24 | Upgrade
|
| Levered Free Cash Flow | - | -233.08 | -495.11 | -398.41 | -1,054 | Upgrade
|
| Unlevered Free Cash Flow | - | -223.6 | -487.73 | -393.11 | -1,052 | Upgrade
|
| Change in Working Capital | - | -301 | -137.45 | 74.37 | 39.7 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.